Skip to main content

Table 2 Preoperative characteristics of matched patients undergone complex valve surgery

From: Del Nido versus HTK cardioplegia for myocardial protection during adult complex valve surgery: a retrospective study

 

DN (n = 73)

HTK (n = 73)

P-value

Male gender [n(%)]

46 (63.0)

44 (60.3)

0.734

Age [P50(P25,P75), year]

56 (47,64)

56 (48,62)

0.677

Weight [P50(P25,P75), kg]

60 (52,65)

61 (54,73)

0.324

BMI

22 (20,25)

23 (21,25)

0.215

Arrhythmia [n(%)]

21 (28.8)

19 (26.0)

0.711

Poor cardiac function(NYHA grade3 to 4) [n(%)]

26 (35.6)

24 (32.9)

0.727

Previous myocardial infarction [n(%)]

1 (1.4)

2 (2.7)

0.560

Previous cardiac surgery [n(%)]

9 (12.3)

8 (10.9)

0.796

Coronary artery disease [n(%)]

24 (43.8)

25 (34.2)

0.841

Infective endocarditis [n(%)]

11 (15.1)

4 (5.5)

0.056

Hypertension [n(%)]

23 (31.5)

27 (37.0)

0.485

Diabetes [n(%)]

5 (6.8)

6 (8.2)

0.754

Previous stroke [n(%)]

7 (9.6)

7 (9.6)

1.000

Pulmonary disease [n(%)]

11 (15.1)

11 (15.1)

1.000

Preoperative CK-MB [P50(P25,P75), U/L]

11.0 (8.9,11.1)

13.0 (10,15.1)

0.070

Preoperative cTnI [P50(P25,P75), ng/mL]

0.02 (0.01,0.04)

0.02 (0.01,0.04)

0.727

Preoperative AST [P50(P25,P75), μu/L]

23.0 (18.0,29.3)

22.8 (18.8,31.3)

0.431

Preoperative creatinine [P50(P25,P75), μmol /L]

84.2 (73.1,94.5)

83 (74.8,100.8)

0.418

EuroSCORE II

4.08 (2.94,6.89)

4.30 (2.79,7.51)

0.902

  1. DN, del Nido; HTK, histidine-tryptophan-ketoglutarate; NYHA, the New York Heart Association; CK-MB, creatine kinase myocardial isoenzyme; cTnI, cardiac troponin I; AST, serum aspartate transaminase